Recombinant human erythropoietin use in hemolytic anemia due to prosthetic heart valves: A promising treatment Academic Article Article uri icon

Overview

MeSH Major

  • Clinical Trials as Topic
  • Neoplasms
  • Patient Selection
  • Research Subjects

abstract

  • Two patients are reported with hemolytic anemia due to red blood cell fragmentation in association with prosthetic heart vales. They were treated with erythropoietin which eliminated the need for packed red blood cell transfusion.

publication date

  • March 3, 2001

Research

keywords

  • Academic Article

Identity

Digital Object Identifier (DOI)

  • 10.1002/1096-8652(200103)66:3<224::AID-AJH1049>3.0.CO;2-E

PubMed ID

  • 11279631

Additional Document Info

start page

  • 224

end page

  • 6

volume

  • 66

number

  • 3